Amrize Ltd
NYSE:AMRZConstruction Materials
+$1.05 today
- Market cap
- $22.10B
- Beta
- -0.09
Volume 3.68M
Average 3.11M
AMRZ Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Amrize LtdNYSE: AMRZ
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 21.3% from a year ago
Cash & equivalents stood at $729M at the end of Q2 FY2026, up 21.3% from a year earlier and down 33.7% from the prior quarter. Over 3 fiscal years it compounded at +76.3% a year.
Context
- Cash & equivalents amounted to 3.0% of total assets at the end of Q2 FY2026, up 0.4 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +21.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 1.92B USD
- Year-over-year change
- +5.4%
- 3-year CAGR
- +76.3%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.92B | +5.4% |
| FY2024 | 2024-12-31 | 1.82B | +64.8% |
| FY2023 | 2023-12-31 | 1.11B | +215.4% |
| FY2022 | 2022-12-31 | 351M | — |
Cash & Equivalents vs competitors
How AMRZ compares with its peers on the latest reported figures
- AMRZ's Jun 2026 cash & equivalents of $729M is the 2nd highest of the 7 companies compared; the peer median is $252.27M.
- Its year-over-year change of +21.3% is the 3rd highest of 7, against a peer median of +11.5%.
- Cash & equivalents amounts to 3.0% of total assets for AMRZ, versus a peer median of 3.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $3.03B | +5.2% | -11.6% | 5.2% | |
AMRZAmrize Ltd | Jun 2026 | $729M | +21.3% | +76.3% | 3.0% |
| Jun 2026 | $665.3M | +872.7% | +45.0% | 10.7% | |
| Jun 2026 | $271M | +17.8% | -31.5% | 2.1% | |
| Jun 2026 | $233.54M | +290.9% | +169.4% | 6.0% | |
| Jun 2026 | $194.2M | -44.1% | +4.3% | 1.2% | |
| Jun 2026 | $112M | -50.2% | -42.8% | 0.5% | |
| Peer median (excluding AMRZ) | $252.27M | +11.5% | -3.7% | 3.6% | |
Competitors are the stored peer set for AMRZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Amrize Ltd
NYSE:AMRZ
Intrinsic Alpha fair value
Locked
Current Price
$40.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.